Forte Biosciences, Inc. (FBRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Forte Biosciences, Inc.
Address
3060 Pegasus Park Drive
Dallas, TX 75247
United States of America (the)
Phone
310 618 6994
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
April 13, 2017
Key Executives
| Name | Title | Pay | Year Born |
| Paul A. Wagner | Chief Executive Officer, President & Chairman | 1.41M | 1970 |
| Barbara K. Finck | Acting Senior Medical Clinician & Director | 600,000 | 1947 |
| Antony A. Riley | Chief Financial Officer | 632,953 | 1967 |
| Christopher Roenfeldt | Chief Operating Officer | 0 | N/A |
AD
Description
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
AD
